Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lakewood-Amedex Biotherapeutics
AddedFeb 17, 2024
UpdatedJul 5, 2026
Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Biotherapeutics

Public

Lakewood Amedex Inc., a biotech company, specializes in developing anti-infective therapeutics.

HQ
Sarasota, FL, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Lakewood Amedex Inc., founded with a mission to address the critical need for novel antimicrobial therapeutics, focuses on developing anti-infective drugs. The company's core vision is to revolutionize the treatment of infectious diseases through innovative therapeutics, specifically their proprietary BisphosphocinsTM. These products aim to reduce hospital stays and avoid lengthy treatments associated with conventional antibiotics, targeting a significant market need in the healthcare industry.

The leadership team at Lakewood Amedex boasts over 100 years of combined experience in the pharmaceutical sector, ensuring a robust pathway from development to market. Notable achievements include the advancement of their BisphosphocinsTM, which hold the potential to significantly impact patient care and healthcare costs. The company’s efforts have positioned it as a key player in the biotechnology space, contributing to the global fight against infectious diseases.

Lakewood-Amedex Biotherapeutics - Similar Companies

Innovative Biologics logo

Innovative Biologics

Actinobac Biomed logo

Actinobac Biomed

X-Biotix Therapeutics logo

X-Biotix Therapeutics

ExoLytics logo

ExoLytics

exolytics.com

Armata Pharmaceuticals logo

Armata Pharmaceuticals

armatapharma.com

Atterx BioTherapeutics logo

Atterx BioTherapeutics

atterx.com

Revagenix logo

Revagenix

revagenix.com

Biolytx Pharmaceuticals logo

Biolytx Pharmaceuticals

biolytx.com

Veloce BioPharma logo

Veloce BioPharma

Biorelix logo

Biorelix

BioPlx logo

BioPlx

SelectX Pharmaceuticals logo

SelectX Pharmaceuticals

Amicrobe logo

Amicrobe

amicrobe.com

Bioharmony Therapeutics logo

Bioharmony Therapeutics

Microbiotix logo

Microbiotix

microbiotix.com

Lakewood-Amedex Biotherapeutics - Quick Facts

Who are Lakewood-Amedex Biotherapeutics' competitors?

Companies similar to Lakewood-Amedex Biotherapeutics include Innovative Biologics, Actinobac Biomed, X-Biotix Therapeutics and ExoLytics.

When was Lakewood-Amedex Biotherapeutics founded?

Lakewood-Amedex Biotherapeutics was founded in 2006.

Where is Lakewood-Amedex Biotherapeutics' headquarters located?

Lakewood-Amedex Biotherapeutics' headquarters is located in Sarasota, FL, US.

When was Lakewood-Amedex Biotherapeutics' last funding round?

Lakewood-Amedex Biotherapeutics' most recent funding round was for $24.1M (USD) in January 2021.

How much has Lakewood-Amedex Biotherapeutics raised to-date?

As of Jan 22, 2021, Lakewood-Amedex Biotherapeutics has raised a total of $29.6M (USD).

How many employees does Lakewood-Amedex Biotherapeutics have?

Lakewood-Amedex Biotherapeutics has 40 employees as of Feb 5, 2024.

Lakewood-Amedex Biotherapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Anti-Infective Drugs
Tags
  • Biotech
  • Healthtech
Unique IDs
  • secCik: 0002079272
  • ticker: LABT
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified